rcca-header
Clinical Trials

Phase 1 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 701 in Subjects With Multiple Myeloma

Type of Cancer
Multiple Myeloma
Site
Hackensack
Sponsor
Amgen
Protocol Number
20170122
Phase of Trial
Phase I
To Learn More Call
(201)-510-0950